In CCA, miR-21 promotes cancer cell proliferation by inhibiting the expression of programmed cell death 4 (PDCD4) and tissue inhibitor of metalloproteinase 3 (TIMP3) [119] by targeting 15-PGDH/HPGD [82]. The gene discussed is TIMP3; the disease is cholangiocarcinoma.